Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ | Zendy

Shutong Shen | Zendy; Huimin Jiang | Zendy; Yihua Bei | Zendy; Jialiang Zhang | Zendy; Haifeng Zhang | Zendy; Hongsheng Zhu | Zendy; Chenlin Zhang | Zendy; Wenming Yao | Zendy; Cong Wei | Zendy; Hongcai Shang | Zendy; Xinli Li | Zendy

Open Access

Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ

Author(s) -

Shutong Shen,

Huimin Jiang,

Yihua Bei,

Jialiang Zhang,

Haifeng Zhang,

Hongsheng Zhu,

Chenlin Zhang,

Wenming Yao,

Cong Wei,

Hongcai Shang,

Xinli Li

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000478641

Subject(s) - medicine , endocrinology , myocardial fibrosis , ovariectomized rat , fibrosis , peroxisome proliferator activated receptor , myocardial infarction , ventricular remodeling , cd36 , cardiac function curve , apoptosis , cardiac fibrosis , heart failure , receptor , biology , estrogen , biochemistry

This study was designed to investigate the therapeutic effect of traditional Chinese medication Qiliqiangxin (QLQX) on adverse cardiac remodeling after myocardial infarction (MI) in bilateral ovariectomized (OVX) female mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research